Dr. Catherine Lutz Zois, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 515 S Maple St, Eaton, OH 45320 Phone: 330-418-0042 |
Thomas J Knobbe, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 501 W Lexington Rd, Eaton, OH 45320 Phone: 937-456-9535 |
News Archive
Warning that patients could be at risk, an interdisciplinary group of multinational investigators is calling on the U.S. Congress and federal regulators to tighten a law that permits use of brain devices to treat rare neuropsychiatric disorders without supporting clinical trials or stringent patient oversight.
The U.S. Food and Drug Administration Commissioner Margaret A. Hamburg, M.D. today released the agency's "Global Engagement Report," detailing the many activities and strategies FDA is using to transform from a domestic to a global public health agency. The report describes the steps the agency is taking to ensure that imported food, drugs, medical devices, and other regulated products meet the same rigorous standards for safety and quality as those manufactured domestically.
US study results show that the genetic abnormality underlying the pediatric condition methyl-CpG binding protein 2 duplication syndrome also causes immune dysfunction.
Johnson and Johnson's (J&J) commonly used over-the-counter painkiller Tylenol has been recalled again in some batches because of complaints of a musty or moldy odor in the product. The company is facing a U.S. congressional probe of quality control lapses in the past as well. The drugs recalled to date include the painkiller Motrin and allergy treatment Benadryl as well as this batch of 100,000 bottles of Tylenol.
› Verified 8 days ago